EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Acute kidney injury after liver cancer ablation: Risk factors and perioperative management

Da-Wei Luo, Hai-Liang Du, Wan-Xing Duan

World Journal of Gastrointestinal Surgery · 2026-11-27 · 18 (11)

DOI: 10.4240/wjgs.124030 ↗
AbstractBibliografische Angaben

Abstract

BACKGROUND Evidence regarding the risk factors for and clinical management of acute kidney injury (AKI) following liver cancer (LC) ablation remains limited. AIM To investigate the incidence and potential risk factors for AKI following LC ablation and explore relevant clinical preventive strategies. METHODS This retrospective study included 168 patients with LC who underwent ablation between May 2022 and February 2026. Patients were classified into AKI (n = 25) and non-AKI (n = 143) groups according to postoperative AKI occurrence. Baseline characteristics, tumor-related characteristics (laterality, TNM stage, tumor size, tumor number, and ablation type), and laboratory parameters were compared between groups. Univariate and multivariable logistic regression analyses were performed to identify factors associated with AKI after LC ablation. RESULTS Age, diabetes, TNM stage, tumor size, hemoglobin (Hb), uric acid (UA), and serum creatinine (SCr) differed significantly between groups. Univariate analysis identified older age, diabetes, larger tumor size, higher UA, and higher SCr levels as potential risk factors, while higher Hb was associated with a lower risk of AKI. Multivariate analysis identified Hb and SCr as independent factors associated with AKI, with higher Hb associated with a lower risk [odds ratio (OR): 0.908, 95% confidence interval (CI): 0.867-0.950, P < 0.001] and higher SCr associated with an increased risk (OR: 1.040, 95%CI: 1.004-1.078, P = 0.031). CONCLUSION Lower preoperative Hb and higher preoperative SCr levels may increase the risk of AKI after LC ablation. Preoperative anemia management and renal function assessment may help identify high-risk patients and guide individualized perioperative renal protection strategies.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →